The role of retrotransposons at the interface of DNA damage and the innate immune response.
2/5 보강
TL;DR
This mini-review discusses recent and still debated insights into L1's role in cancer, including non-cell-autonomous effects mediated by extracellular vesicles, its role in promoting cellular plasticity, and therapeutic opportunities through reverse transcriptase inhibition.
OpenAlex 토픽 ·
Chromosomal and Genetic Variations
Bacterial Genetics and Biotechnology
DNA Repair Mechanisms
This mini-review discusses recent and still debated insights into L1's role in cancer, including non-cell-autonomous effects mediated by extracellular vesicles, its role in promoting cellular plastici
APA
Pooja Vikraman, Teresa Davoli, Paolo Mita (2026). The role of retrotransposons at the interface of DNA damage and the innate immune response.. Current opinion in cell biology, 99, 102625. https://doi.org/10.1016/j.ceb.2026.102625
MLA
Pooja Vikraman, et al.. "The role of retrotransposons at the interface of DNA damage and the innate immune response.." Current opinion in cell biology, vol. 99, 2026, pp. 102625.
PMID
41747652 ↗
Abstract 한글 요약
LINE-1 (L1) retrotransposons are increasingly recognized as key players in cancer biology. While traditionally viewed as mutators through their endonuclease (EN) activity, recent findings show that L1 elements can also activate innate immune pathways independently of EN activity, particularly type I interferon signaling via "viral mimicry." These dual functions position L1 at the intersection of genome regulation and innate immune response. From this perspective, this mini-review discusses recent and still debated insights into L1's role in cancer, including non-cell-autonomous effects mediated by extracellular vesicles, its role in promoting cellular plasticity, and therapeutic opportunities through reverse transcriptase inhibition. Together, these findings highlight L1 retrotransposons as drivers of tumor development and potential clinical targets.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.